It is reported that the early upregulation of FOXM1 during head and neck cancer progression, rendering it as an attractive diagnostic biomarker for early cancer detection and its candidate mechanistic targets, CEP55 and HELLS, as indicators of malignant conversion and progression [16]. This evidence concerns the gene CEP55 and cancer.